Viewing Study NCT02040935


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2025-12-27 @ 10:37 PM
Study NCT ID: NCT02040935
Status: COMPLETED
Last Update Posted: 2019-08-22
First Post: 2014-01-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of SC Administration of Trastuzumab (Herceptin) by SID at Home in HER2-Positive EBC Participants
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module